Dna Fragile Site Breakage as a Measure of Chemical Exposure and Predictor of the Susceptibility to Form Chromosomal Rearrangements
Year: 2016
Type: dissertation
Abstract: Cancer development is often initiated by various genetic abnormalities including chromosomal translocations which require DNA breakage. These DNA breaks can occur through exogeneous chemical exposures and/or at regions particularly susceptible to breakage termed “common fragile sites (CFS)”. To test the hypothesis that fragile site breakage underlies the formation of chromosomal rearrangements, we focused on RET/PTC rearrangements in papillary thyroid carcinoma. All genes participating in the two most common types of RET/PTC rearrangements, RET/PTC1 and RET/PTC3, are located within common fragile sites. Fragile sites are sensitive to a variety of environmental chemicals and chemotherapeutic drugs and we have shown that treatment of human thyroid cells with laboratory fragile site-inducing chemicals can cause the formation of RET/PTC rearrangement. Here, we demonstrate that treatment with non-cytotoxic levels of environmental chemicals, benzene and diethylnitrosamine, and chemotherapeutic agents, etoposide and doxorubicin, generate significant DNA breakage within RET at levels similar to those generated by laboratory fragile site-inducing chemicals. These results suggest the role of long-term exposure to these chemicals in the generation of RET/PTC rearrangements. DNA topoisomerases I and II maintain structural integrity by recognizing and cleaving DNA secondary structures such as those at fragile sites. Co-treatment of human thyroid cells with APH and topoisomerase inhibitors significantly altered APH-induced breakage within RET demonstrating their involvement in initiating APH-induced breakage at RET.
Author: Lehman, Christine Lehman
Institution: Wake Forest University
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
Funder: National Institutes of Health
OpenAlex ID: W7046661975
